Risperdal Patient Slams J&J's Bid To Dodge Damages Trial

Law360 (August 13, 2019, 7:18 PM EDT) -- A young man on Monday urged a Pennsylvania judge to proceed with a punitive damages trial in September against Johnson & Johnson over claims that the anti-psychotic Risperdal he took as a child caused him to develop breasts.

Nicholas Murray said that under Maryland law, a plaintiff can recover punitive damages if they can show that a defendant knew about the defect and its danger and disregarded the potential harm for others. Murray in 2015 was awarded a $1.75 million verdict against Johnson & Johnson unit Janssen Pharmaceuticals Inc., which found that company failed to properly disclose the risks of abnormal...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS